Psychiatry and Neurology, Neurology · Columbia, MD
NPI
1932176294
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11055 Little Patuxent Pkwy, Ste 209
Columbia, MD, 21044
Phone (410) 884-0191
Groups this clinician bills Medicare through
Medicare paid, 2024
$180K
1,865 services
Medicare patients, 2024
828
Average age 76
Drug cost, 2024
$1.0M
1,010 prescriptions
Company payments, 2025
$16.15
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Merrill Ansher was code 99215 (office e&m - established), 507 times for 346 patients. In total Merrill Ansher billed 1,865 services in 20 codes, and Medicare paid $180K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 507 | 346 | $141.45 | $72K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 428 | 203 | $26.73 | $11K |
| 99205 Office E&M - New | Office | 229 | 229 | $171.85 | $39K |
| 95816 Neurologic | Facility | 218 | 198 | $44.25 | $9,646 |
| 99214 Office E&M - Established | Office | 135 | 124 | $91.14 | $12K |
| 95886 Electrical Nerve Conductivity | Office | 95 | 76 | $77.85 | $7,396 |
| 99213 Office E&M - Established | Office | 55 | 54 | $70.49 | $3,877 |
| 95910 Electrical Nerve Conductivity | Office | 28 | 27 | $133.13 | $3,728 |
| 99212 Office E&M - Established | Office | 28 | 28 | $46.48 | $1,301 |
| 95816 Neurologic | Office | 25 | 25 | $315.10 | $7,878 |
| 99204 Office E&M - New | Office | 22 | 22 | $126.76 | $2,789 |
| 95909 Electrical Nerve Conductivity | Office | 21 | 21 | $105.09 | $2,207 |
| 95822 Neurologic | Facility | 21 | 17 | $43.66 | $917 |
| 95908 Electrical Nerve Conductivity | Office | 17 | 17 | $87.89 | $1,494 |
| 95911 Electrical Nerve Conductivity | Office | 11 | 11 | $160.26 | $1,763 |
By year: 2022 $156K for 1,349 services; 2023 $178K for 1,596 services; 2024 $180K for 1,865 services.
Medicare prescription drug claims, 2024
In 2024, the drug Merrill Ansher prescribed most often to Medicare patients was Donepezil Hcl, with 161 prescriptions and refills. In total Merrill Ansher wrote 1,010 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 161 | 407 | 69 | $2,251 |
| Levetiracetam Generic | 93 | 221 | 27 | $4,178 |
| Lamotrigine Generic | 89 | 120 | Under 11 | $1,683 |
| Gabapentin Generic | 80 | 208 | 30 | $1,684 |
| Memantine Hcl Generic | 65 | 159 | 27 | $5,060 |
| Pregabalin Generic | 32 | 96 | Under 11 | $956 |
| Primidone Generic | 31 | 79 | 14 | $1,056 |
| Sumatriptan Succinate Generic | 21 | 21 | Under 11 | $193 |
| Lamictal Lamotrigine | 21 | 21 | Under 11 | $14K |
| Glatopa Glatiramer Acetate | 20 | 39 | Under 11 | $140K |
| Ubrelvy Ubrogepant | 20 | 20 | Under 11 | $16K |
| Topiramate Generic | 19 | 57 | Under 11 | $452 |
| Propranolol Hcl Er Propranolol Hcl | 18 | 54 | Under 11 | $1,190 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 16 | 48 | Under 11 | $570 |
| Lacosamide Generic | 15 | 37 | Under 11 | $1,610 |
Brand drugs: 140 claims; generic drugs: 870 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Merrill Ansher $16.15 ($16.15 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $16.15.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $16.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.